Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate‐Lowering Therapy: A Phase 2, Randomized, Open‐Label, Multicenter, Active‐Controlled Trial
Objective To evaluate the efficacy and safety of firsekibart versus colchicine for prophylaxis against acute gout flares in participants initiating urate‐lowering therapy (ULT). Methods In this randomized, multicenter, open‐label, active‐controlled, phase 2 trial, participants were randomized (1:1:1...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2025-11-01
|
| Serie: | ACR Open Rheumatology |
| Accesso online: | https://doi.org/10.1002/acr2.70111 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|